LECT2在脓毒症相关肝损伤中的作用及机制研究

Role and mechanism of LECT2 in sepsis-associated liver injury

  • 摘要: 背景 白细胞来源趋化因子2(leukocyte cell-derived chemotaxin 2,LECT2)由肝细胞产生并介导炎症过程,可能在脓毒症肝损伤中发挥核心作用。目的 通过细胞与动物实验探讨LECT2 在脓毒症相关肝损伤中的作用及机制,评估LECT2敲除的保护潜力。方法 使用脂多糖(lipopolysaccharide,LPS)刺激THLE-2 细胞在体外模拟脓毒症肝细胞损伤,将THLE-2细胞随机分为4 组:未处理组(Control)、LECT2 外源性补充组(LECT2)、LPS 刺激组(LPS)和LPS 刺激同时LECT2 外源性补充组(LPS+LECT2)。评估LECT2 对细胞活性、凋亡、死亡及上清液丙氨酸氨基转移酶(alanine aminotransferase,ALT)和天门冬氨酸氨基转移酶(aspartate aminotransferase,AST)水平的影响。使用盲肠结扎穿刺法(cecal ligation and puncture,CLP)构建小鼠脓毒症模型。将小鼠按随机数字表法分为6 组(每组n=6):野生型(wild-type,WT)小鼠、LECT2 基因敲除(LECT2 knockout,LECT2 KO)小鼠、野生型小鼠尾静脉注射AAV8 对照载体(WT+AAV8-vehicle)、野生型小鼠尾静脉注射AAV8 包装全长LECT2 质粒(WT+AAV8-LECT2 overexpression)、野生型小鼠尾静脉注射100 μL PBS (WT+PBS)和野生型小鼠尾静脉注射100μL rLECT2(WT+ rLECT2)。对6 组小鼠分别构建脓毒症模型以及与之对照的假手术模型。HE染色检测各组小鼠肝组织病理情况,检测白介素-1β(interleukin 1 beta,IL-1β)、白介素-6(interleukin 6,IL-6)和肿瘤坏死因子α(tumor necrosis factor alpha,TNF-α)等炎症因子的表达情况,检测各组血清ALT和AST水平。结果 体外细胞实验:与LPS组相比,LPS+LECT2组细胞活性进一步降低(P<0.01),细胞损伤加重;细胞培养上清液中ALT浓度进一步升高(P<0.05)。动物实验:脓毒症后肝脏和血清LECT2 表达均较假手术组降低(P均<0.01);LECT2 KO组肝脏损伤病理评分比WT组低(P<0.01);LECT2 KO组炎症因子IL-1β 比WT组低(P<0.05);LECT2 KO组TNF-α 比WT组低(P<0.001);LECT2 KO组血清ALT比WT组低(P<0.01);LECT2 KO组血清AST比WT组低(P<0.01)。结论 LECT2 敲除可保护脓毒症相关肝损伤,抑制炎症因子产生并改善肝组织病理和功能。

     

    Abstract: Background Leukocyte cell-derived chemotaxin 2 (LECT2), secreted by hepatocytes, participates in the regulation of inflammatory responses and may play a pivotal role in sepsis-associated liver injury. Objective To investigate the function and molecular mechanisms of LECT2 in sepsis-associated liver injury and to evaluate the protective effects of LECT2 gene knockout. Methods An in vitro model of septic hepatocellular injury was established by stimulating THLE-2 cells with lipopolysaccharide (LPS). Cells were randomly assigned to four groups: untreated control (Control), exogenous LECT2 supplementation (LECT2), LPS stimulation (LPS), and LPS with exogenous LECT2 (LPS+LECT2). The effects of LECT2 on cell viability, apoptosis, cell death, and levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in supernatants were assessed. In vivo, a murine sepsis model was generated using cecal ligation and puncture (CLP). Mice were randomly divided into six groups (n=6 per group): wild-type (WT) mice, LECT2 knockout (LECT2 KO) mice, WT mice receiving tail vein injection of AAV8 control vector (WT+ AAV8-vehicle), WT mice injected with AAV8 carrying full-length LECT2 plasmid (WT+AAV8-LECT2 overexpression), WT mice injected with 100 μL PBS as vehicle control (WT+PBS), and WT mice injected with 100 μL recombinant LECT2 protein (WT+ rLECT2). CLP-induced sepsis models and corresponding sham operations were performed in all groups. Liver histopathological changes were evaluated by H&E staining, expression levels of inflammatory cytokines including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor- α (TNF-α) were measured, and serum concentrations of ALT and AST were determined. Results In vitro, compared with the LPS group, the LPS+LECT2 group showed further reduced THLE-2 cell viability (P<0.01), aggravated cellular injury, and a further increase in ALT concentration in the culture supernatant (P<0.05). In vivo, hepatic and serum LECT2 expression in sepsis model groups was markedly downregulated compared to sham groups (both P<0.01). The liver histopathological injury score in the LECT2 KO group was lower than in the WT group (P<0.01). Hepatic expression of IL-1β and TNF-α in the LECT2 KO group was lower than in the WT group (P<0.05 and P<0.001, respectively). Serum levels of ALT and AST in the LECT2 KO group were also significantly lower than in the WT group (both P<0.01). Conclusion LECT2 gene knockout attenuates sepsis-associated liver injury, suppresses inflammatory cytokine release, and improves liver histopathological structure and function.

     

/

返回文章
返回